Maravai LifeSciences
MRVI
#5396
Rank
ยฃ1.01 B
Marketcap
ยฃ2.77
Share price
-0.27%
Change (1 day)
-34.98%
Change (1 year)

Revenue for Maravai LifeSciences (MRVI)

Revenue in 2025 (TTM): ยฃ0.14 Billion

According to Maravai LifeSciences 's latest financial reports the company's current revenue (TTM ) is ยฃ0.14 Billion. In 2024 the company made a revenue of ยฃ0.20 Billion a decrease over the revenue in the year 2023 that were of ยฃ0.22 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Maravai LifeSciences from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.14 B-28.93%
2024 ยฃ0.20 B-8.99%
2023 ยฃ0.22 B-68.93%
2022 ยฃ0.72 B23.27%
2021 ยฃ0.59 B184.08%
2020 ยฃ0.20 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
ยฃ0.48 B 234.02% Jersey
Novavax
NVAX
ยฃ0.76 B 432.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
ยฃ0.1 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
ยฃ16.39 M-88.64%๐Ÿ‡ฌ๐Ÿ‡ง UK